We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 3,482

CMS Reminds Providers to Report Changes in Ownership
  • Krieg DeVault
  • USA
  • March 5 2018

CMS’ recent MLN Connects e-Newsletter reminds providers of their obligation to report changes in ownership to CMS and highlighted the 2016 Office of

What the Blazes is a Healthcare Reimbursement Attorney, Anyway?
  • Nexsen Pruet
  • USA
  • January 30 2018

As I sit on a delayed plane attempting to fight my way back home, I have the difficult task of attempting to clarify what it is I do. When I was a kid

Globalizing Your Compliance Program
  • Ropes & Gray LLP
  • USA
  • January 25 2018

Multinational companies continue to face intense enforcement scrutiny related to their global compliance practices by oversight authorities

OIG Report Suggests Improvements to FSMA Enforcement
  • Shook Hardy & Bacon LLP
  • USA
  • October 9 2017

A report from the Office of the Inspector General (OIG) of the U.S. Department of Health and Human Services has concluded that the Food and Drug

Does "Meaningful Use" Mean Widespread Abuse? - HHS-OIG's Review of EHR Incentive Payments
  • Morvillo Abramowitz Grand Iason & Anello PC
  • USA
  • June 30 2017

In 2009, as part of the HITECH Act, the federal government funded an incentive program by which health care providers who implemented and used

GSA IG Questions Pricing Evaluation of Professional Services Schedules
  • Morgan Lewis & Bockius LLP
  • USA
  • March 29 2017

On March 21, the Office of Inspector General for the General Services Administration issued an audit report finding that the Federal Acquisition

The Strategic Approach to Vendor Negotiations
  • Bryan Cave LLP
  • USA
  • March 17 2017

On March 17, 2017, Jonathan and I sat down with Bryan Cave Partner Sean Christy in the latest Episode of The Bank Account for a discussion of the

Drug and Device Makers Suggest Anti-Kickback Safe Harbor Clarifications to Encourage Value-Based Health Care Arrangements
  • Ropes & Gray LLP
  • USA
  • March 17 2017

In response to the annual solicitation by the Office of Inspector General (“OIG”) of the U.S. Department of Health and Human Services (“HHS”) for

Pharmaceutical Manufacturers and Healthcare Leaders cite Fraud and Abuse Laws as Obstacle to Value-Based Arrangements
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • March 15 2017

As the healthcare industry moves towards value-based purchasing, pay-for-performance, and other payment reform models, industry leaders have

New Exclusion Rule on the Horizon
  • Davis Wright Tremaine LLP
  • USA
  • March 13 2017

On January 12, 2017, the Department of Health and Human Services Office of Inspector General (“OIG”) published a final rule which provides guidance on